Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-17

Charlie Wright

Researcher

Graduate Student Researcher

3 pubs

  • Antiparkinson Agents
  • Parkinson Disease
  • Medication Reconciliation
  • Dopamine D2 Receptor Antagonists
  • Aged
  • Carbidopa
  • Drug Combinations
  • Drug Interactions
  • Hospitalization
  • Humans
  • Levodopa
  • Male
  • Metoclopramide
  • Pharmacists
  • Disease Progression

Biography and Research Information

OverviewAI-generated summary

Charlie Wright's research focuses on medication management and its impact on patient care, particularly within the context of neurological disorders and aging populations. Wright has published on the importance of medication reconciliation for patients with Parkinson's disease, highlighting potential challenges and best practices. Their work also extends to fundamental molecular mechanisms, with publications addressing dysregulated signaling pathways in osteosarcoma and the analysis of gene expression programs in neuroblastoma. These diverse publications indicate an interest in both clinical applications of pharmacology and the underlying biological processes of disease.

Metrics

  • Publications: 3

Selected Publications

  • The Importance of Medication Reconciliation in a Patient with Parkinson’s Disease (2025)
    The Senior Care Pharmacist DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

1 Collaborator 3 Institutions 1 Country

Top Collaborators

Similar Researchers

Based on overlapping research topics